参考文献/References:
[1] Cai MY,Tong ZT,Zheng F,et al.EZH2 protein:a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies[J].Gut,2011,60(7):967-976.
[2] Yuen MF,Cheng CC,Lauder IJ,et al.Early detection of hepatocellular carcinoma increases the chance of treatment:Hong Kong experience[J].Hepatology,2000,31(2):330-335.
[3] Bruix J,Sherman M,Practice Guidelines Committee,American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma[J].Hepatology,2005,42(5):1208-1236.
[4] Altekruse SF,McGlynn KA,Reichman ME.Hepatocellular carcinoma incidence,mortality,and survival trends in the United States from 1975 to 2005[J].JClin Oncol,2005,27(9):1485-1491.
[5] Hunter T.Tyrosine phosphorylation:thirty years and counting[J].CurrOpin Cell Biol,2009,21(2):140-146.
[6] Yarden Y,Sliwkowski MX.Untangling the ErbB signalling network[J].NatRev Mol Cell Biol,2001,2(2):127-137.
[7] Hsu JL,Huang SY,Chow NH,et al.Stable-isotope dimethyl labeling for quantitative proteomics[J].Anal Chem,2003,75(24):6843-6852.
[8] Sun T,Aceto N,Meerbrey KL,et al.(2011)Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase[J].Cell,144(5):703-718.
[9] 郑耿龙,麦瑞琴,郑高哲,等.PTPN12在乳腺癌中的表达及其影响指标研究[J].中国医药导报,2017,14(5):90-93.
Zheng GL,Mai RQ,Zheng GZ,et,al.Study of the expression of PTPN12 in the patients with breast cancer and its influenec indexes[J].China Medical Herald,2017,14(5):90-93.
[10] 阮瑞扬,陈修荣,赵世元.抗EZH2自身抗体IgG在肝癌患者血清中的表达及意义[J].现代检验医学杂志,2017,32(2):72-74.
Ruan RY,Chen XR,Zhao SY.Expression and significance of anti EZH2 autoantibody IgG in hepatocellular carcinoma patients serum samples[J].Journal of Modern Laboratory Medicine,2017,32(2):72-74.
[11] 张利云,付丽萍,徐 娟,等.自身抗体在肝癌诊断中的意义[J].现代检验医学杂志,2006,21(2):70-72.
Zhang LY,Fu LP,Xu J,et al.Significance of auto-antibody in diagnosisof liver disease[J].Journal of Modern Laboratory Medicine,2006,21(2):70-72.
[12] Yamamoto J,Kosuge T,Takayama T,et al.Recurrence of hepatocellular carcinoma after surgery[J].Br J Surg,1996,83(9):1219-1222.
[13] Lee JS,Heo J,Libbrecht L,et al.A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells[J].Nat Med,2006,12(4):410-416.
[14] Moradpour D,Wands JR.The molecular pathogenesis of hepatocellular carcinoma[J].J Viral Hepat,1994,1(1):17-31.
[15] Tabor E.Tumor suppressor genes,growth factor ge-nes,and oncogenes inhepatitis B virus-associated hepatocellular carcinoma[J].J Med Virol,1994,42(4):357-365.
[16] Hui AM,Makuuchi M,Li X.Cell cycle regulators and human hepatocarcinogenesis[J].Hepatogastroenterology,1998,45(23):1635-1642.
收稿日期:2017-09-28
修回日期:2017-11-20
相似文献/References:
[1]邓旭,王晓亮.肝细胞癌患者血清趋化因子CXCR12和SA的表达及临床意义[J].现代检验医学杂志,2015,30(06):49.[doi:10.3969/j.issn.1671-7414.2015.06.014]
DENG Xu,WANG Xiao-liang.Expression and Clinical Significance of Serum CXCR12
and SA in Patients with Hepatocarcinoma[J].Journal of Modern Laboratory Medicine,2015,30(01):49.[doi:10.3969/j.issn.1671-7414.2015.06.014]
[2]毛丽萍,何义民,韩 刚,等.血浆Dickkopf同源物1检测对肝细胞癌的诊断价值[J].现代检验医学杂志,2016,31(05):62.[doi:10.3969/j.issn.1671-7414.2016.05.016]
MAO Li-ping,HE Yi-min,HAN Gang,et al.Diagnosis Value of Detecting Plasma Dickkopf-1
Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(01):62.[doi:10.3969/j.issn.1671-7414.2016.05.016]
[3]阮瑞杨,陈修荣,赵世元.抗EZH2自身抗体IgG在肝癌患者血清中的表达及意义[J].现代检验医学杂志,2017,32(02):72.[doi:10.3969/j.issn.1671-7414.2017.02.019]
RUAN Rui-yang,CHEN Xiu-rong,ZHAO Shi-yuan.Expression and Significance of Anti EZH2 Autoantibodies IgG
in Hepatocellular Carcinoma Patient's Serum Samples[J].Journal of Modern Laboratory Medicine,2017,32(01):72.[doi:10.3969/j.issn.1671-7414.2017.02.019]
[4]毛丽萍,王跃国,王 健,等.CMIA法测定血清DCP与AFP对肝细胞癌的诊断价值[J].现代检验医学杂志,2018,33(06):38.[doi:10.3969/j.issn.1671-7414.2018.06.010]
MAO Li-ping,WANG Yue-guo,WANG Jian,et al.Diagnostic Value of the Serum DCP and AFP Determined by CMIA in Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(01):38.[doi:10.3969/j.issn.1671-7414.2018.06.010]
[5]吴良银a,李文丽b,刘 俊a.肝细胞癌患者生存预后相关长链非编码RNA(LncRNA)的生物信息学分析[J].现代检验医学杂志,2019,34(04):18.[doi:10.3969/j.issn.1671-7414.2019.04.005]
WU Liang-yina,LI Wen-lib,LIU Juna.Bioinformatics Analysis of Long-Chain Non-Coding RNA Related
to Survival and Prognosis in Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2019,34(01):18.[doi:10.3969/j.issn.1671-7414.2019.04.005]
[6]吴良银a,李文丽b,刘 俊b.基于GEO数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析[J].现代检验医学杂志,2021,36(06):106.[doi:10.3969/j.issn.1671-7414.2021.06.022]
WU Liang-yin,LI Wen-li,LIU Jun.Screening and Bioinformatics Analysis of Potential Biomarkers for Virus-associated Hepatocellular Carcinoma Based on GEO Data[J].Journal of Modern Laboratory Medicine,2021,36(01):106.[doi:10.3969/j.issn.1671-7414.2021.06.022]
[7]陈 偲,李忠辉a,王 颖b.miR-198 通过靶向ZEB2 调控EMT 过程抑制肝癌细胞增殖和迁移的机制研究[J].现代检验医学杂志,2022,37(04):23.[doi:10.3969/j.issn.1671-7414.2022.04.005]
CHEN Si,LI Zhong-huia,WANG Yingb.Study on the Mechanism of miR-198 Inhibiting the Proliferation and Migration of Hepatoma Cells by Regulating EMT Process by Targeting ZEB2[J].Journal of Modern Laboratory Medicine,2022,37(01):23.[doi:10.3969/j.issn.1671-7414.2022.04.005]
[8]王 路,叶 莎,韩 霞,等.循环外泌体miRNA 检测对肝细胞癌临床诊断效能的Meta 分析[J].现代检验医学杂志,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
WANG Lu,YE Sha,HAN Xia,et al.Meta-Analysis of the Diagnostic Value of Circulating Exosomes miRNA Detection for Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(01):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
[9]时晓晓a,董 翔a,于若卉b,等.miR-203a-3p 靶向GLS1 调控HCC 细胞增殖、迁移、侵袭的机制研究[J].现代检验医学杂志,2022,37(05):86.[doi:10.3969/j.issn.1671-7414.2022.05.018]
SHI Xiao-xiaoa,DONG Xianga,YU Ruo-huib,et al.Mechanism of miR-203a-3p Targeting GLS1 to Regulate the Proliferation, Migration and Invasion of HCC Cells[J].Journal of Modern Laboratory Medicine,2022,37(01):86.[doi:10.3969/j.issn.1671-7414.2022.05.018]
[10]吴翠婷,周雪辉,张婉馨.基于生物学信息分析筛选晚期肝细胞癌患者接受PD-1 抑制剂治疗后糖酵解相关基因差异表达并构建生存获益模型与验证[J].现代检验医学杂志,2023,38(05):34.[doi:10.3969/j.issn.1671-7414.2023.05.007]
WU Cuiting,ZHOU Xuehui,ZHANG Wanxin.Differential Expression of Glycolysis-related Genes in Patients with Advanced Hepatocellular Carcinoma Treated with PD-1 Inhibitors Screened Based on Biological Information Analysis, and Survival Benefit Model Constructed and Verified[J].Journal of Modern Laboratory Medicine,2023,38(01):34.[doi:10.3969/j.issn.1671-7414.2023.05.007]